Armotraz
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
Strengths: 1mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Arimidex
- Therapeutic class
Aromatase Inhibitor
- Pharmacological class
Nonsteroidal Aromatase Inhibitor
- Known off-label uses
gynaecomastia
- Contraindications
hypersensitivity to anastrozole; pregnancy; breastfeeding; premenopausal women
- Minor side effects
hot flushes; asthenia; arthralgia; nausea; rash
- Moderate side effects
bone fractures; osteoporosis; depression; elevated liver enzymes
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
N/A
- Duration
N/A
- Storage instructions
Store below 30°C.
- Drug interactions
tamoxifen; oestrogen-containing therapies
- Age restrictions
Adults only.
- Pregnancy and breastfeeding
Pregnancy: Contraindicated. Breastfeeding: Contraindicated.
Precautions and warnings
bone density monitoring recommended; may cause fatigue; regular cholesterol assessments needed
Serious side effects
severe skin reactions — requires immediate medical attention; myocardial infarction — requires immediate medical attention
Patient summary
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
Mechanism of action
Anastrozole acts as a potent, highly selective non-steroidal aromatase inhibitor, preventing the conversion of androgens to oestrogens in peripheral tissues, which suppresses oestrogen levels.
Armotraz
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
Editorial Notes
- Active ingredient(s): Anastrozole
- Listed indication(s): Breast Cancer, Adjuvant Therapy
Available option
- 60 tablets - 1 mg1023-1-mg-12861